Estraderm combined with Prempro

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Progesterone Receptor Assay Positive Other Serious 11/7/1996 67 Female 12/30/2005 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 1/13/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 1/31/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 2/6/2006 Consumer United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1999 57 Female 134 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/16/2001 49 Female 125 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2002 55 Female 175 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1977 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 11/1/2002 Female 12/23/2005 United States
Primary
Secondary
Thrombosis Other Serious 5/3/1997 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/25/1999 60 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2001 Female 12/23/2005 United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 1/21/1999 74 Female 2/7/2006 United States
Primary
Secondary
Breast Cancer Hospitalization 1/1/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 2/18/2003 66 Female 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/26/2001 69 Female 210 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 3/31/1999 58 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2002 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/25/2003 Female 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 50 Female 160 lb 12/23/2005 United States
Primary
Secondary
Breast Cancer Other Serious 9/18/2002 Female 12/23/2005 United States
Primary
Secondary
Stress Required Intervention 7/10/2000 62 Female 144 lb 2/21/2006 Physician United States
Primary
Secondary
Concomitant
Stress Required Intervention 7/10/2000 62 Female 144 lb 3/6/2006 Physician United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 10/11/1996 65 Female 3/6/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 2/20/2002 Female 3/7/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/16/2003 60 Female 189 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 11/14/2001 70 Female 135 lb 12/23/2005 United States
Primary
Secondary
Concomitant
Progesterone Receptor Assay Positive Other Serious 1/1/2002 67 Female 3/23/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/16/2002 67 Female 3/28/2006 United States
Primary
Secondary
Viral Pharyngitis Hospitalization 1/1/2001 50 Female 320 lb 4/10/2006 Physician United States
Primary
Concomitant
Stress Required Intervention 7/10/2000 62 Female 144 lb 4/7/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 10/1/2001 Female 2/8/2006 Consumer United States
Primary
Secondary
Neoplasm Malignant Other Serious 12/14/1995 54 Female 190 lb 4/18/2006 Physician United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Required Intervention 7/10/2000 62 Female 144 lb 5/3/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 5/18/2004 Female 5/5/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 5/24/2006 Consumer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 6/26/2001 73 Female 5/24/2006 United States
Primary
Secondary
Breast Cancer Female Other Serious 4/1/2002 Female 5/30/2006 United States
Primary
Secondary
Breast Cancer Other Serious 10/1/2001 Female 6/8/2006 Consumer United States
Primary
Secondary
Uterine Leiomyoma Required Intervention 7/10/2000 62 Female 144 lb 6/16/2006 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 4/1/2002 66 Female 6/26/2006 United States
Primary
Secondary
Nerve Injury Other Serious 12/19/2001 61 Female 130 lb 7/5/2006 Lawyer United States
Primary
Secondary
Concomitant
Scar Other Serious 1/1/1999 55 Female 157 lb 7/11/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2000 Female 7/12/2006 Lawyer United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/12/2006 Lawyer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 1/1/2000 Female 7/17/2006 United States
Primary
Secondary
Ovarian Cancer Metastatic Other Serious 8/1/2002 59 Female 162 lb 7/26/2006 Lawyer United States
Primary
Secondary
Concomitant
Oestrogen Receptor Assay Positive Other Serious 8/11/1998 64 Female 8/2/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/24/2001 62 Female 8/2/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/11/1998 Female 8/17/2006 Lawyer United States
Primary
Secondary
Scar Other Serious 7/17/1997 55 Female 157 lb 9/20/2006 Physician United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 7/1/2002 63 Female 150 lb 10/13/2006 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious 12/1/2002 Female 12/15/2006 Lawyer United States
Primary
Secondary
Mastectomy Other Serious Female 8/31/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/20/2002 Female 10/10/2006 United States
Primary
Secondary
Physical Disability Other Serious 1/1/1997 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 66 Female 9/18/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 8/11/1998 72 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/24/2001 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 10/11/1996 65 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 2/20/2002 Female 9/18/2006 Lawyer United States
Primary
Secondary
Progesterone Receptor Assay Positive Other Serious 8/16/2002 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Scar Other Serious Female 9/18/2006 Lawyer United States
Primary
Secondary
Concomitant
Scar Other Serious 3/31/1999 64 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/25/2003 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 9/30/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/1/2002 Female 9/18/2006 Lawyer United States
Primary
Secondary
Pain Other Serious 9/19/2002 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 10/1/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious 5/18/2004 60 Female 9/18/2006 Lawyer United States
Primary
Secondary
Oestrogen Receptor Assay Positive Other Serious 6/26/2001 73 Female 9/18/2006 Lawyer United States
Primary
Secondary
Breast Cancer Other Serious Female 9/18/2006 Lawyer United States
Primary
Secondary
Malignant Breast Lump Removal Other Serious 12/19/2001 Female 9/18/2006 Lawyer United States
Primary
Secondary
Injury Other Serious 11/7/1996 67 Female 9/18/2006 Lawyer United States
Primary
Secondary
Vena Cava Thrombosis Hospitalization 3/24/1999 55 Female 157 lb 1/25/2007 United States
Primary
Secondary
Vulvovaginal Mycotic Infection Other Serious 1/1/1995 51 Female 170 lb 2/28/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/15/1999 67 Female 138 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/15/1999 67 Female 138 lb 3/1/2007 United States
Primary
Secondary
Concomitant
Visual Disturbance Other Serious 1/1/1998 55 Female 3/1/2007 United States
Primary
Secondary
Concomitant
Tenderness Other Serious 1/1/1998 65 Female 130 lb 3/9/2007 United States
Primary
Secondary
Concomitant
Venous Insufficiency Other Serious 8/15/1999 54 Female 118 lb 3/17/2007
Primary
Secondary
Wound Infection Staphylococcal Other Serious 1/1/1991 57 Female 192 lb 3/23/2007 United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/1985 57 Female 155 lb 3/27/2007 Physician United States
Primary
Secondary
Concomitant
Vaginal Infection Other Serious 2/1/1993 59 Female 212 lb 3/27/2007 United States
Primary
Secondary
Concomitant
Vulvar Dysplasia Other Serious 1/1/1993 62 Female 169 lb 3/29/2007 United States
Primary
Secondary
Concomitant
Ultrasound Breast Abnormal Other Serious 1/1/2000 60 Female 180 lb 3/28/2007 Lawyer United States
Primary
Secondary
Concomitant
Spondylitis Other Serious 1/1/1992 65 Female 143 lb 4/3/2007 Physician United States
Primary
Secondary
Breast Cancer Other Serious Female 11/3/2006 Lawyer United States
Primary
Secondary
Vertigo Positional Other Serious 12/3/1997 60 Female 150 lb 4/5/2007 United States
Primary
Secondary
Concomitant
Wound Necrosis Other Serious 2/19/2001 58 Female 112 lb 4/5/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 4/1/2002 66 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/20/1998 56 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/1997 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer In Situ Other Serious 10/11/1996 56 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/24/2001 67 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 5/18/2004 59 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/7/1996 58 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 6/26/2001 73 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/11/1998 72 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 3/4/1999 57 Female 134 lb 12/22/2006 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 9/20/1999 54 Female 162 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 11/14/2002 59 Female 165 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 9/25/2003 72 Female 157 lb 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 4/1/2002 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 8/16/2002 67 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/1/2000 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 12/19/2001 Female 12/22/2006 United States
Primary
Secondary
Breast Cancer Other Serious 1/21/1999 74 Female 12/22/2006 United States
Primary
Secondary
Wheelchair User Other Serious 1/28/1992 58 Female 160 lb 4/14/2007 United States
Primary
Secondary
Concomitant
Vascular Calcification Other Serious 8/7/1995 50 Female 165 lb 4/16/2007 United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 12/1/2002 Female 1/31/2007 Consumer United States
Primary
Secondary
Vitrectomy Other Serious 7/22/1991 58 Male 160 lb 4/20/2007 United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 8/6/1998 59 Female 130 lb 4/20/2007 United States
Primary
Secondary
Concomitant
Uterine Polyp Other Serious 4/30/1999 57 Female 130 lb 4/21/2007 Physician United States
Primary
Secondary
Concomitant
Tricuspid Valve Incompetence Other Serious 6/3/2003 64 Female 150 lb 4/24/2007 United States
Primary
Secondary
Concomitant
Uterine Polyp Other Serious 10/1/1999 64 Female 130 lb 4/26/2007 United States
Primary
Secondary
Concomitant
Vulvovaginal Dryness Other Serious 10/20/1992 49 Female 126 lb 4/26/2007 United States
Primary
Secondary
Concomitant
Vaginal Discharge Other Serious 1/1/2000 61 Female 125 lb 5/10/2007 Physician United States
Primary
Secondary
Concomitant
Irritable Bowel Syndrome Other Serious 7/7/1998 65 Female 185 lb 2/7/2007 Physician United States
Primary
Secondary
Concomitant
Uterine Leiomyoma Other Serious 1/1/1995 67 Female 5/30/2007 Lawyer United States
Primary
Secondary
Uterine Leiomyoma Other Serious 1/1/1997 56 Female 140 lb 6/5/2007 Physician United States
Primary
Secondary
Concomitant
Breast Cancer Female Other Serious Female 4/6/2007 Lawyer United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary
Breast Cancer Female Other Serious Female 4/6/2007 United States
Primary
Secondary

Drug Data